[Therapeutic effects of meropenem against severe infections in patients with hematopoietic disorders. Hanshin Study Group of Hematopoietic Disorders and Infection].

Abstract

The efficacy and the safety of meropenem (MEPM), a newly developed carbapenem antibiotic, were investigated in 150 patients with severe infections complicated with hematopoietic disorders. 1. Clinical responses in 132 patients who were evaluable for effectiveness were excellent in 33 patients, good in 45, fair in 10 and poor in 44, with an efficacy rate of… (More)

Topics

Cite this paper

@article{Sugiyama1992TherapeuticEO, title={[Therapeutic effects of meropenem against severe infections in patients with hematopoietic disorders. Hanshin Study Group of Hematopoietic Disorders and Infection].}, author={H. Sugiyama and Akira Horiuchi and H. Hasegawa and Takako Kitani and Shinichi Tagawa and Toru Masaoka and Hideyuki Tejima and T. Yonezawa and Harumi Take and Hiroyuki Kawagoe}, journal={The Japanese journal of antibiotics}, year={1992}, volume={45 6}, pages={687-96} }